Akamai Technologies CapEx decreased by 22.8% to $101.69M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.7%, from $117.78M to $101.69M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 11.5% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $107.23M | $70.68M | $63.84M | $51.01M | $74.22M | $50.80M | $65.25M | $141.70M | $112.31M | $133.50M | $70.40M | $93.75M | $90.99M | $112.80M | $92.89M | $117.78M | $145.54M | $112.78M | $131.69M | $101.69M |
| QoQ Change | — | -34.1% | -9.7% | -20.1% | +45.5% | -31.6% | +28.5% | +117.2% | -20.7% | +18.9% | -47.3% | +33.2% | -2.9% | +24.0% | -17.7% | +26.8% | +23.6% | -22.5% | +16.8% | -22.8% |
| YoY Change | — | — | — | — | -30.8% | -28.1% | +2.2% | +177.8% | +51.3% | +162.8% | +7.9% | -33.8% | -19.0% | -15.5% | +31.9% | +25.6% | +59.9% | -0.0% | +41.8% | -13.7% |